A 26-year-old male shares his hair loss journey, using finasteride and fish oil daily since the pandemic. He briefly tried biotin and microneedling but stopped due to inconvenience.
A 23-year-old shared their positive 4-month progress using 1mg oral finasteride and topical minoxidil for hair loss, noting increased hair health and confidence despite initial shedding. Other users shared similar experiences and results, with some using Kirkland Costco minoxidil.
RU58841 helped regrow hairline without side effects for a bodybuilder using PEDs. The treatment included RU58841, finasteride, minoxidil, GKH-Cu, microneedling, and HGH.
The conversation discusses the HMI-115 trial for hair loss, which was expected to end around July 2023 due to a late participant. Participants also mention Minoxidil, finasteride, and RU58841 as treatments.
A user reports high DHT levels despite taking finasteride and is concerned about inconsistent blood test results. They also take modafinil, vitamin D, and magnesium supplements.
Setipiprant trial for hair loss failed, showing no difference between placebo and treatment. Discussion also noted placebo users reporting side effects.
Psoriasis shampoo with salicylic acid can improve scalp health and hair quality better than Nizoral. It helps create a cleaner environment for hair growth, especially when using treatments like finasteride.
The user shared progress pictures showing significant hair regrowth after 7 months of using oral finasteride and topical minoxidil. The results sparked a mix of disbelief and congratulations, with some users discussing initial hair shedding and side effects.
The user stopped taking oral finasteride due to depression and now uses a topical finasteride/minoxidil mix with some scalp irritation. They plan to start derma stamping and have seen some improvement in their hair over three years, which others have noticed and encouraged them to continue their efforts.
Finasteride can affect hormone levels within two weeks, and a break of several weeks is recommended for baseline results. Monitoring E2 and testosterone is suggested to assess the risk of gynecomastia.